45
GevRx Nutraceuticals, Inc. raises $300K under Reg D
Company raise · Raising · STATEN ISLAND, NY · Form D filed 2026-09-18
First raise on EDGAR
Why now — by persona
Relevant to: Executive & technical recruiting, B2B software & services sales, Commercial banking / treasury, D&O and management-liability insurance, Outsourced accounting / CFO. Lead card pending.
People on the filing
| Dylan Tyler Spiel | Vice President |
| James Thomas Christopher | President, Secretary and Treasurer |
| Douglas Thomas Spiel, M.D. | Chief Executive Officer and Chief Medical Director |
| Michael J. Betley, Ph.D. | Chief Scientific Officer |
| Mary Stephen Esposito | Director |
Signed by James Christopher, President, Secretary and Treasurer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.